Biodesix, Inc. announced a one-for-twenty reverse stock split of its common stock.
The reverse stock split will be effective on September 15, 2025, reducing the number of outstanding shares.
Stockholders will receive one new share for every 20 pre-split shares they hold.
Reverse Stock Split
Every 20 shares of pre-split common stock will be reclassified into one new share.
Impact on Shares
Number of shares outstanding will decrease from about 156 million to about 8 million.
Stockholder Uniformity
The reverse stock split will affect all stockholders uniformly.
- The reverse stock split aims to streamline the company's share structure and enhance stock liquidity.
- Stockholders with fractional shares will receive a cash payment in lieu of such fractions.
Biodesix's reverse stock split is a strategic move to optimize the company's capital structure and improve operational efficiency.